Riskpilot← Back to searchSign inGet full accessVEJGAARD FYSIOTERAPI ApS
APSActiveCVR 31155061Heimdalsgade 11Physiotherapy activities · NACE 8695Est. 200718 employees
Revenue 2024
DKK 3,2M
+5% vs 2023
EBITDA margin
20.4%
-16% vs 2023
Equity ratio
75.5%
Financial strength
Net profit 2024
DKK 404K
-20% vs 2023
| Revenue | DKK 3,2M | +5% |
| EBITDA | DKK 652K | -16% |
| Net profit | DKK 404K | -20% |
| Total assets | DKK 2,1M | -5% |
| Equity | DKK 1,6M | -6% |
| Employees | 18 | — |
Legal name
VEJGAARD FYSIOTERAPI ApS
CVR number
31155061
Legal form
Anpartsselskab
NACE code
8695 · Physiotherapy activities
Founded
22. november 2007
Share capital
DKK 125.000
Employees
18 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af én direktør
Company purpose
Selskabets formål er at drive fysioterapeutvirksomhed
Address
Heimdalsgade 11
Phone
+4598161942
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.474 | 1.291 | 1.761 | 1.751 | 2.324 | 2.084 | 2.930 | 2.765 | 2.512 | 2.655 | 3.429 | 3.040 | 3.201 |
| Staff expenses | -1.108 | -1.145 | -1.194 | -1.606 | -1.800 | -1.627 | -2.065 | -2.032 | -1.881 | -2.079 | -2.561 | -2.264 | -2.456 |
| EBITDA | 366 | 139 | 567 | 145 | 524 | 456 | 865 | 733 | 631 | 575 | 868 | 776 | 652 |
| Depreciation & amort. | -71 | -101 | -101 | -162 | -93 | -184 | -146 | -147 | -128 | -136 | -135 | -135 | -134 |
| EBIT | 295 | 38 | 466 | -17 | 431 | 273 | 719 | 586 | 503 | 440 | 733 | 641 | 518 |
| Net financials | 6 | 6 | 13 | 11 | 2 | -44 | -10 | -8 | -3 | -6 | -2 | 10 | 1 |
| Profit before tax | 301 | 44 | 479 | -6 | 433 | 229 | 709 | 578 | 500 | 434 | 731 | 651 | 519 |
| Tax | 76 | 14 | 129 | 1 | 97 | 54 | 157 | 128 | 111 | 96 | 161 | 144 | 115 |
| Net profit | 225 | 30 | 350 | -7 | 336 | 175 | 553 | 451 | 390 | 337 | 569 | 507 | 404 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.220 | 998 | 1.449 | 1.572 | 1.808 | 2.824 | 2.508 | 2.333 | 2.346 | 2.143 | 2.215 | 2.164 | 2.057 |
| Equity | 983 | 787 | 1.138 | 1.131 | 1.467 | 1.312 | 1.695 | 1.646 | 1.535 | 1.473 | 1.742 | 1.649 | 1.553 |
| Long-term debt | 24 | 24 | 0 | 0 | 0 | 0 | 0 | 50 | 137 | 139 | 0 | 0 | 0 |
| Short-term debt | 214 | 186 | 311 | 441 | 341 | 1.512 | 813 | 637 | 673 | 531 | 474 | 515 | 505 |
| Total debt | 238 | 210 | 311 | 441 | 341 | 1.512 | 813 | 687 | 811 | 670 | 474 | 515 | 505 |
EBITDA margin
20.4%
This company
15.8%
Market median
+29% vs market
20122024
Equity ratio
75.5%
This company
38.2%
Market median
+98% vs market
20122024
Return on equity
26.0%
This company
18.4%
Market median
+41% vs market
20122024
Net profit margin
12.6%
This company
8.1%
Market median
+56% vs market
20122024
Asset turnover
1.56×
This company
1.12×
Market median
+39% vs market
20122024
Debt / equity
0.32×
This company
0.62×
Market median
+48% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PH Management | Management | 2017 | — | — |
JS Founder | Founder | 2007 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Peter Skriver Holding ApS | Company | 100.0% | 100.0% | 2017 |
SKALKAM HOLDING ApS | Company | 100.0% | 100.0% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Peter Skriver Holding ApS
VEJGAARD FYSIOTERAPI ApS Board members of VEJGAARD FYSIOTERAPI ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Peter Holch Skriver | Management | 0 companies |
| Jess Skriver | Founder | 0 companies |